ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY Trademark

Trademark Overview

On Thursday, April 14, 2011, a trademark application was filed for ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY with the United States Patent and Trademark Office. The USPTO has given the ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY trademark a serial number of 85294803. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 22, 2014. This trademark is owned by Bristol-Myers Squibb Company. The ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
ability apixaban investigation to lower the incidence of thromboembolic events in cancer therapy

General Information

Serial Number85294803
Word MarkABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY
Filing DateThursday, April 14, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2011

Trademark Statements

Disclaimer with Predetermined Text"APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 18, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, December 22, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 22, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 12, 2014EXTENSION 5 GRANTED
Thursday, May 8, 2014EXTENSION 5 FILED
Thursday, May 8, 2014TEAS EXTENSION RECEIVED
Tuesday, November 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2013EXTENSION 4 GRANTED
Wednesday, November 13, 2013EXTENSION 4 FILED
Wednesday, November 13, 2013TEAS EXTENSION RECEIVED
Tuesday, May 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2013EXTENSION 3 GRANTED
Friday, May 3, 2013EXTENSION 3 FILED
Friday, May 3, 2013TEAS EXTENSION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, November 13, 2012EXTENSION 2 GRANTED
Thursday, November 8, 2012EXTENSION 2 FILED
Thursday, November 8, 2012TEAS EXTENSION RECEIVED
Friday, May 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, May 10, 2012EXTENSION 1 GRANTED
Tuesday, April 17, 2012EXTENSION 1 FILED
Thursday, May 10, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 17, 2012TEAS EXTENSION RECEIVED
Tuesday, November 15, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2011NOTICE OF PUBLICATION
Wednesday, August 17, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 16, 2011ASSIGNED TO LIE
Wednesday, August 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 25, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 25, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 18, 2011EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
Monday, July 18, 2011EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, June 29, 2011ASSIGNED TO EXAMINER
Monday, April 25, 2011TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, April 25, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 18, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

events cancer therapy thromboembolic incidence apixaban investigation lower ability relating pharmaceutical preparations human trials clinical scientific research namely conducting